Return to program book search
Use of Botox for Inflammatory Diseases
Friday, March 21
Mile High Ballroom 1DEF
7:15 AM - 8:45 AM
Erin Gilbert, MD, PhD, FAAD
Following this course, the attendee should be able to:
- Distinguish between the proposed mechanisms of action of botulinum neurotoxin type A in the context of inflammatory skin disease.
- Apply this knowledge clinically in treating common inflammatory dermatoses.
This session is directed towards physicians interested in learning more about the immunomodulatory effects of botulinum neurotoxin type A (BoNT-A) and how these can be applied to cutaneous disorders. The discussion will include specific mechanisms of action of BoNT-A in neurogenic inflammation and introduce treatment protocols for acne, rosacea, psoriasis and emerging protocols for orolabial HSV.